Page last updated: 2024-08-23

etoposide and Neuroectodermal Tumors

etoposide has been researched along with Neuroectodermal Tumors in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amant, F; Coenegrachts, L; Debiec-Rychter, M; Decloedt, J; Moerman, P; Tousseyn, T1
Chan, AW; Cianchetti, M; Deschler, DG; Liebsch, NJ; Varvares, MA; Wang, JJ1
Amey, JS; Carmena, D; Higgins, CF; Jansen-Rosseck, N; Nebrig, M; Sardini, A; Weylandt, KH; Wiedenmann, B1
Hess, CF; Jürgens, H; Klingebiel, T; Koscielniak, E; Pertl, U; Pötter, R; Rossi, R; Schött, C; Spaar, HJ; Treuner, J; van Heek-Romanowski, R; Willnow, U1
Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B1
Dhodapkar, K; Dunkel, IJ; Finlay, J; Gardner, S; Sapp, M; Thoron, L1

Trials

1 trial(s) available for etoposide and Neuroectodermal Tumors

ArticleYear
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine

2002

Other Studies

5 other study(ies) available for etoposide and Neuroectodermal Tumors

ArticleYear
Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype.
    Anticancer research, 2011, Volume: 31, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Differentiation; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 17; Cisplatin; Etoposide; Female; Humans; Neuroectodermal Tumors; Phenotype; Sarcoma, Endometrial Stromal; Translocation, Genetic; Uterine Neoplasms

2011
Risk of sinonasal-cutaneous fistula after treatment for advanced sinonasal cancer.
    Journal of surgical oncology, 2012, Volume: 105, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cutaneous Fistula; Etoposide; Female; Fistula; Follow-Up Studies; Humans; Male; Middle Aged; Nasal Cavity; Neuroectodermal Tumors; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms; Paranasal Sinuses; Postoperative Complications; Radiotherapy; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma; Young Adult

2012
ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:3

    Topics: Acridine Orange; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Cells, Cultured; Chloride Channels; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endosomes; Etoposide; Genes, MDR; Humans; Immunoenzyme Techniques; Kidney; Muscle Proteins; Neuroectodermal Tumors

2007
Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
    Medical and pediatric oncology, 1998, Volume: 30, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Germany; Humans; Hyperthermia, Induced; Ifosfamide; Male; Neuroectodermal Tumors; Prospective Studies; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Treatment Outcome

1998
Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Medical and pediatric oncology, 2002, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medical Records; Medulloblastoma; Neoadjuvant Therapy; Neoplasm Staging; Neuroectodermal Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2002